Atara Announces Stock Offering

(RTTNews) - Atara Biotherapeutics Inc (ATRA) on Tuesday said it has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of approximately $125.0 million.

In addition, Atara Bio expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the number of shares of common stock sold in connection with the offering. All of the shares in the offering will be sold by Atara Bio.

Goldman, Sachs & Co. and Citigroup Global Markets Inc. are acting as joint book-running managers for the proposed offering. William Blair & Company, LLC, Canaccord Genuity Group, Inc. and JMP Securities LLC are acting as co-managers.